Open AccessRapid prenatal diagnosis of chromosome aneuploidies by interphase fluorescence in situ hybridization: a one‐year clinical experience with high‐risk and urgent fetal and postnatal samples
Author(s) -
BRYNDORF THUE,
LUNDSTEEN CLAES,
LAMB ALLEN,
CHRISTENSEN BRITTA,
PHILIP JOHN
Publication year - 2000
Publication title -
acta obstetricia et gynecologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.401
H-Index - 102
eISSN - 1600-0412
pISSN - 0001-6349
DOI - 10.1034/j.1600-0412.2000.079001008.x
Subject(s) - fluorescence in situ hybridization , prenatal diagnosis , medicine , aneuploidy , chromosome , cytogenetics , chorionic villus sampling , obstetrics , fetus , pathology , biology , genetics , pregnancy , gene
Objectives. To evaluate the clinical utility of rapid prenatal and postnatal detection of common chromosome aneuploidies by interphase fluorescence in situ hybridization (FISH) analysis with DNA probes. Design. Four hundred and seventy‐seven high‐risk and/or urgent amniotic fluid, chorionic villus and fetal and postnatal blood samples were prospectively examined by FISH with probes specific for chromosomes 13, 18, 21, X, and Y and results were reported within 48 hours. All FISH results were followed by conventional chromosome analysis, if possible. Setting. Cytogenetic service laboratory at the tertiary referral center, Rigshospitalet in Copenhagen. Main outcome measures. The fraction of clinically significant chromosome aneuploidies that was detected by FISH analysis, and the fraction of terminations that was based on FISH and ultrasound results rather than on conventional cytogenetic results. Results. The FISH assay detected 76% of the clinically significant chromosome abnormalities as determined by subsequent cytogenetic analysis. Seventy‐two percent of the terminations of the chromosomally abnormal pregnancies were based on FISH and ultrasound results rather than on conventional cytogenetic results. Conclusion. FISH analysis is a clinically useful adjunctive tool to conventional pre‐ and postnatal cytogenetic analysis. The assay rapidly detects the majority of clinically significant chromosome abnormalities, thus facilitating difficult pre‐ and postnatal clinical decisions.